Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

9-ING-41 in Pediatric Patients With Refractory Malignancies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04239092
Recruitment Status : Recruiting
First Posted : January 23, 2020
Last Update Posted : May 2, 2022
Information provided by (Responsible Party):
Actuate Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : December 2024
Publications of Results: